Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ikuko Ooka

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cureus|July 12, 2026
Kakkonto-Induced Pneumonitis: A Case ReportIkuko Ooka, Tetsu Hirakawa, Yoshito Temma, et al.
Thoracic Cancer|January 25, 2022
First-line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptor G719S and de novo T790M mutationsNoriaki Ito, Takeshi Masuda, Ikuko Ooka, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cureus|July 12, 2026
Kakkonto-Induced Pneumonitis: A Case ReportIkuko Ooka, Tetsu Hirakawa, Yoshito Temma, et al.
Thoracic Cancer|January 25, 2022
First-line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptor G719S and de novo T790M mutationsNoriaki Ito, Takeshi Masuda, Ikuko Ooka, et al.
Pageof 1